Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03411681 · ClinicalTrials.gov registry record · NA

Resistance Exercise and Muscle Protein Synthesis in Obese Adults

A NA study, sponsored by University of Illinois at Urbana-Champaign.

Completed
Registry status
NA
Development phase
19
Enrollment target

NCT03411681 is a NA study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 19 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03411681, a NA study, has completed, sponsored by University of Illinois at Urbana-Champaign.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target

Study Summary

Obesity has numerous comorbidities that are associated with exceedingly high healthcare costs. In addition to well- characterized impairments in lipid and glucose metabolism, obesity is associated with altered protein metabolism. We have recently observed that obese individuals are essentially nonresponsive to protein ingestion with respect to myofibrillar protein synthesis. This suggests that skeletal muscle remodeling in obese individuals is impaired possibly contributing to a poor metabolic quality of muscle. Resistance exercise is known to strongly augment muscle protein synthesis in response to protein ingestion. The purpose of this research is to determine the muscle protein synthetic response during post-exercise recovery in obese individuals. Using stable isotope methodology, we will determine the postprandial muscle protein synthetic response in 14 male and female obese adults (Age: 20-45, BMI: 30-39.9 kg/m2) immediately after an acute bout of resistance exercise. Participants will be sedentary (\< 60 min exercise/ week) and weight stable for a minimum of 6 months. During the testing blood and muscle samples will be collected. In addition participants will be asked to perform moderate intensity resistance exercise. Completion of the proposed research will identify the role of resistance exercise in the maintenance of skeletal muscle tissue after the consumption of a protein-dense meal in obese people.

Interventions

  • OTHER Resistance Exercise

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2017-01-01
Est. Completion 2018-05-01
Phase NA

What the Registry Record Tells You About NCT03411681

The ClinicalTrials.gov registry entry for NCT03411681 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Urbana-Champaign, which has 129 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Resistance Exercise is the first listed.

NCT03411681 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03411681 about?

NCT03411681 is a clinical study titled "Resistance Exercise and Muscle Protein Synthesis in Obese Adults". Obesity has numerous comorbidities that are associated with exceedingly high healthcare costs. In addition to well- characterized impairments in lipid and glucose metabolism, obesity is associated with altered protein metabolism. We have recently observed that obese individuals are essentially nonre...

What is the current status of trial NCT03411681?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2017-01-01. Estimated completion is 2018-05-01.

What interventions are being tested in trial NCT03411681?

The interventions under investigation include: Resistance Exercise (OTHER).

Who is sponsoring clinical trial NCT03411681?

This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.